Loading...
XHKG
2348
Market cap241mUSD
Dec 05, Last price  
1.25HKD
1D
0.81%
1Q
0.00%
Jan 2017
-46.35%
IPO
194.12%
Name

Dawnrays Pharmaceutical (Holdings) Ltd

Chart & Performance

D1W1MN
XHKG:2348 chart
P/E
3.02
P/S
1.61
EPS
0.38
Div Yield, %
6.40%
Shrs. gr., 5y
-0.90%
Rev. gr., 5y
2.22%
Revenues
1.06b
-7.89%
734,002,000788,797,000919,945,000947,710,0001,082,110,0001,286,683,0001,081,044,000856,539,000914,973,000783,803,000985,000,000824,351,000882,483,000948,938,000950,007,0001,024,270,0001,165,155,0001,277,682,0001,151,145,0001,060,309,000
Net income
565m
+73.29%
105,704,00065,878,000101,157,000102,037,000118,388,000166,840,000146,307,000114,506,000153,099,000205,145,000302,198,000265,917,000292,978,000303,960,000255,430,000268,130,000358,175,000358,057,000326,000,000564,940,000
CFO
220m
-34.93%
34,489,00050,613,000130,551,00097,799,000138,987,000252,344,00082,986,000203,624,000231,262,000377,798,000298,322,000320,258,000390,741,000274,294,000275,837,000302,903,000393,139,000434,266,000338,400,000220,200,000
Dividend
Sep 16, 20240.015 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.
URL
https://www.dawnrays.com/
IPO date
Jul 11, 2003
Employees
1,132
Domiciled in
HK
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT